Advertisement

Biochemistry (Moscow)

, Volume 78, Issue 2, pp 194–203 | Cite as

Action of two phospholipases A2 purified from Bothrops alternatus snake venom on macrophages

  • S. S. Setúbal
  • A. S. Pontes
  • J. L. Furtado
  • C. V. Xavier
  • F. L. Silva
  • A. M. Kayano
  • L. F. M. Izidoro
  • A. M. Soares
  • L. A. Calderon
  • R. G. Stábeli
  • J. P. ZulianiEmail author
Article

Abstract

The in vitro effects of BaltTX-I, a catalytically inactive Lys49 variant of phospholipase A2 (PLA2), and BaltTX-II, an Asp49 catalytically active PLA2 isolated from Bothrops alternatus snake venom, on thioglycollate-elicited macrophages (TG-macrophages) were investigated. At non-cytotoxic concentrations, the secretory PLA2 BaltTX-I but not BaltTX-II stimulated complement receptor-mediated phagocytosis. Pharmacological treatment of TG-macrophages with staurosporine, a protein kinase C (PKC) inhibitor, showed that this kinase is involved in the increase of serum-opsonized zymosan phagocytosis induced by BaltTX-I but not BaltTX-II secretory PLA2, suggesting that PKC may be involved in the stimulatory effect of this toxin in serum-opsonized zymosan phagocytosis. Moreover, BaltTX-I and -II induced superoxide production by TG-macrophages. This superoxide production stimulated by both PLA2s was abolished after treatment of cells with staurosporine, indicating that PKC is an important signaling pathway for the production of this radical. Our experiments showed that, at non-cytotoxic concentrations, BaltTX-I may upregulate phagocytosis via complement receptors, and that both toxins upregulated the respiratory burst in TG-macrophages.

Key words

snake venom PLA2 macrophages phagocytosis PKC superoxide inflammation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Naito, M. (1993) Arch. Histol. Cytol., 56, 331–351.PubMedCrossRefGoogle Scholar
  2. 2.
    Aderem, A., and Underhill, T. A. (1999) Annu. Rev. Immunol., 17, 593–623.PubMedCrossRefGoogle Scholar
  3. 3.
    Underhill, D. M., and Goodridge, H. S. (2012) Nat. Rev. Immunol., 12, 492–502.PubMedCrossRefGoogle Scholar
  4. 4.
    Van Lookeren Campagne, M., Wiesmann, C., and Brown, E. J. (2007) Cell Microbiol., 9, 2095–2102.PubMedCrossRefGoogle Scholar
  5. 5.
    Ross, G. D., and Vetvicka, V. (1993) Clin. Exp. Immunol., 92, 181–184.PubMedCrossRefGoogle Scholar
  6. 6.
    Williams, M. A., and Solomkin, J. S. (1999) J. Leukoc. Biol., 65, 725–736.PubMedGoogle Scholar
  7. 7.
    Schmidt, A., Caron, E., and Hall, A. (2001) Mol. Cell. Biol., 21, 438–448.PubMedCrossRefGoogle Scholar
  8. 8.
    Caron, E. (2003) J. Cell Sci., 116, 435–440.PubMedCrossRefGoogle Scholar
  9. 9.
    Lim, J., Wiedemann, A., Tzircotis, G., Monkley, S. J., Critchley, D. R., and Caron, E. (2007) Mol. Biol. Cell., 18, 976–985.PubMedCrossRefGoogle Scholar
  10. 10.
    Carman, C. V., and Springer, T. A. (2003) Curr. Opin. Cell Biol., 15, 547–556.PubMedCrossRefGoogle Scholar
  11. 11.
    Babior, B. M. (2004) Curr. Opin. Immunol., 16, 42–47.PubMedCrossRefGoogle Scholar
  12. 12.
    Forman, H. J., and Torres, M. (2002) Am. J. Respir. Crit. Care Med., 166, S4–S8.PubMedCrossRefGoogle Scholar
  13. 13.
    Six, D. A., and Dennis, E. A. (2000) Biochim. Biophys. Acta, 1488, 1–19.PubMedCrossRefGoogle Scholar
  14. 14.
    Teixeira, C. F., Landucci, E. C., Antunes, E., Chacur, M., and Cury, Y. (2003) Toxicon, 42, 947–962.PubMedCrossRefGoogle Scholar
  15. 15.
    Soares, A. M., Fontes, M. R. M., and Giglio, J. R. (2004) Curr. Org. Chem., 8, 1677–1690.CrossRefGoogle Scholar
  16. 16.
    Zuliani, J. P., Fernandes, C. M., Zamuner, S. R., Gutierrez, J. M., and Teixeira, C. F. P. (2005) Toxicon, 45, 335–346.PubMedCrossRefGoogle Scholar
  17. 17.
    Zuliani, J. P., Gutierrez, J. M., Casais e Silva, L. L., Sampaio, S. C., and Teixeira, C. F. P. (2005) Toxicon, 46, 523–532.PubMedCrossRefGoogle Scholar
  18. 18.
    Kini, R. M. (1997) in Venom Phospholipase A 2 Enzymes. Structure, Function and Mechanism (Kini, M. R., ed.) John Wiley & Sons, New York.Google Scholar
  19. 19.
    Burke, J. E., and Dennis, E. A. (2009) Science, 23, 49–59.Google Scholar
  20. 20.
    Gambero, A., Landucci, E. C., Toyama, M. H., Marangoni, S., Giglio, J. R., Nader, H. B., Dietrich, C. P., De Nucci, G., and Antunes, E. (2002) Biochem. Pharmacol., 63, 65–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Gambero, A., Thomazzi, S. M., Cintra, A. C., Landucci, E. C., De Nucci, G., and Antunes, E. (2004) Toxicon, 44, 473–481.PubMedCrossRefGoogle Scholar
  22. 22.
    Landucci, E. C. T., Castro, R. C., Toyama, M., Giglio, J. R., Cintra, A. C., Giglio, J. R., Marangoni, S., Oliveira, B., Cirino, G., Antunes, E., and De Nucci, G. (1998) Eur. J. Pharmacol., 349, 257–263.CrossRefGoogle Scholar
  23. 23.
    Andriao-Escarso, S. H., Soares, A. M., Rodrigues, V. M., Angulo, Y., Diaz-Oreiro, C., Lomonte, B., Gutierrez, J. M., and Giglio, J. R. (2000) Biochimie, 82, 755–763.PubMedCrossRefGoogle Scholar
  24. 24.
    Costa, T. R., Menaldo, D. L., Oliveira, C. Z., Santos-Filho, N. A., Teixeira, S. S., Nomizo, A., Fuly, A. L., Monteiro, M. C., de Souza, B. M., Palma, M. S., Stabeli, R. G., Sampaio, S. V., and Soares, A. M. (2008) Peptides, 29, 1645–1656.PubMedCrossRefGoogle Scholar
  25. 25.
    Laemmli, U. K. (1970) Nature, 227, 680–685.PubMedCrossRefGoogle Scholar
  26. 26.
    Gutierrez, J. M., Avila, C., Rojas, E., and Cerdas, L. (1988) Toxicon, 26, 411–413.PubMedCrossRefGoogle Scholar
  27. 27.
    Setubal, S. S., Pontes, A. S., Furtado, J. L., Kayano, A. M., Stabeli, R. G., and Zuliani, J. P. (2011) J. Venom. Anim. Toxins Incl. Trop. Dis., 17, 430–441.Google Scholar
  28. 28.
    Madhavi, N., and Das, V. N. (1994) Cancer Lett., 84, 31–41.PubMedCrossRefGoogle Scholar
  29. 29.
    Moura-da-Silva, A. M., and Baldo, C. (2012) Toxicon, 60, 280–289.PubMedCrossRefGoogle Scholar
  30. 30.
    Arlinghaus, F. T., and Eble, J. A. (2012) Toxicon, 60, 512–519.PubMedCrossRefGoogle Scholar
  31. 31.
    Guo, C., Liu, S., Yao, Y., Zhang, Q., and Sun, M. Z. (2012) Toxicon, 60, 302–311.PubMedCrossRefGoogle Scholar
  32. 32.
    Moreira, V., Gutierrez, J. M., Soares, A. M., Zamuner, S. R., Purgatto, E., and Teixeira, C. F. P. (2008) Toxicon, 52, 428–439.PubMedCrossRefGoogle Scholar
  33. 33.
    Ownby, C. L., Selistre-de-Araujo, H. S., White, S. P., and Fletcher, J. E. (1999) Toxicon, 37, 411–445.PubMedCrossRefGoogle Scholar
  34. 34.
    Ponce-Soto, L. A., Lomonte, B., Gutierrez, J. M., Rodrigues-Simioni, L., Novello, J. C., and Marangoni, S. (2007) Biochim. Biophys. Acta, 1770, 585–593.PubMedCrossRefGoogle Scholar
  35. 35.
    Kudo, I., and Murakami, M. (2002) Prostaglandins Other Lipid Mediat., 68-69, 3–58.PubMedCrossRefGoogle Scholar
  36. 36.
    Taylor, A. C. (1961) Exp. Cell Res., 8, 154–173.PubMedCrossRefGoogle Scholar
  37. 37.
    Vishwanath, B. S., Kini, R. M., and Gowda, T. V. (1987) Toxicon, 25, 501–515.PubMedCrossRefGoogle Scholar
  38. 38.
    Allen, L. H., and Aderem, A. (1995) J. Exp. Med., 182, 829–840.PubMedCrossRefGoogle Scholar
  39. 39.
    Larsen, E. C., DiGennaro, J. A., Saito, N., Matha, S., Loegering, D. J., Mazurkiewicz, J. M., and Lennartz, M. R. (2000) J. Immunol., 165, 2809–2817.PubMedGoogle Scholar
  40. 40.
    Nishizuka, Y. (1995) FASEB J., 9, 484–496.PubMedGoogle Scholar
  41. 41.
    Kashiwagi, K., Shirai, Y., Kuriyama, M., Sakai, N., and Saito, N. (2002) J. Biol. Chem., 277, 18037–18045.PubMedCrossRefGoogle Scholar
  42. 42.
    Newton, A. C. (2001) Chem. Rev., 101, 2353–2364.PubMedCrossRefGoogle Scholar
  43. 43.
    Newton, A. C. (2003) Biochem. J., 370, 361–371.PubMedCrossRefGoogle Scholar
  44. 44.
    Fay, A. J., Qian, X., Jan, Y. N. J., and Jan, L. Y. (2006) Proc. Natl. Acad. Sci. USA, 103, 17548–17553.PubMedCrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2013

Authors and Affiliations

  • S. S. Setúbal
    • 1
  • A. S. Pontes
    • 1
  • J. L. Furtado
    • 1
  • C. V. Xavier
    • 1
  • F. L. Silva
    • 1
  • A. M. Kayano
    • 2
  • L. F. M. Izidoro
    • 3
  • A. M. Soares
    • 2
  • L. A. Calderon
    • 2
  • R. G. Stábeli
    • 1
    • 2
  • J. P. Zuliani
    • 1
    • 2
    Email author
  1. 1.Laboratório de Bioquímica e Biotecnologia e Laboratório de Cultivo Celular e Anticorpos MonoclonaisInstituto de Pesquisas em Patologias Tropicais, IPEPATRO/FIOCRUZ RondôniaPorto Velho-ROBrazil
  2. 2.Centro de Biomoléculas Aplicadas à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de MedicinaUniversidade Federal de Rondônia, UNIRPorto Velho-ROBrazil
  3. 3.Faculdade de Ciências Integradas do PontalUniversidade Federal de Uberlandia, UFUItuiutaba-MGBrazil

Personalised recommendations